{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T21:17:46Z","timestamp":1791839866558,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,21]]},"DOI":"10.7759\/cureus.47418","type":"journal-article","created":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T10:40:10Z","timestamp":1697884810000},"source":"Crossref","is-referenced-by-count":2,"title":["Review of Topical Sodium Heparin 1000 IU\/g Gel in Symptomatic Uncomplicated Superficial Thrombophlebitis"],"prefix":"10.7759","author":[{"given":"Francesc","family":"Cabr\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jairo A","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"Rodr\u00edguez-Garc\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora V","family":"Breier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Ballarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2004.05.015","article-title":"The epidemiology of chronic venous insufficiency and varicose veins","volume":"15","author":"Beebe-Dimmer JL","year":"2005","unstructured":"Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005, 15:175-84. 10.1016\/j.annepidem.2004.05.015","journal-title":"Ann Epidemiol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.15266","article-title":"Effectiveness of topical interventions to prevent or treat intravenous therapy-related phlebitis: a systematic review","volume":"29","author":"Goulart CB","year":"2020","unstructured":"Goulart CB, Cust\u00f3dio CS, Vasques CI, Ferreira EB, Diniz Dos Reis PE. Effectiveness of topical interventions to prevent or treat intravenous therapy-related phlebitis: a systematic review. J Clin Nurs. 2020, 29:2138-49. 10.1111\/jocn.15266","journal-title":"J Clin Nurs"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1726028","article-title":"The influence of topically administered heparin on peripheral microcirculation of the skin: a double-blind, randomized, controlled preliminary study on 50 healthy subjects","volume":"37","author":"Denzinger M","year":"2021","unstructured":"Denzinger M, Held M, Amr A, Krau\u00df S, Bender D, Daigeler A, Wenger A. The influence of topically administered heparin on peripheral microcirculation of the skin: a double-blind, randomized, controlled preliminary study on 50 healthy subjects. J Reconstr Microsurg. 2021, 37:694-703. 10.1055\/s-0041-1726028","journal-title":"J Reconstr Microsurg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.333.7562.287","article-title":"Varicose veins and their management","volume":"333","author":"Campbell B","year":"2006","unstructured":"Campbell B. Varicose veins and their management. Br Med J. 2006, 333:287-92. 10.1136\/bmj.333.7562.287","journal-title":"Br Med J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/85.22.1865","article-title":"Use of heparin as a topical antithrombotic and antiinflammatory agent","volume":"85","author":"Katakkar SB","year":"1993","unstructured":"Katakkar SB. Use of heparin as a topical antithrombotic and antiinflammatory agent. J Natl Cancer Inst. 1993, 85:1865-6. 10.1093\/jnci\/85.22.1865","journal-title":"J Natl Cancer Inst"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14813\/ibra.1.4_10","article-title":"Safety of topical heparin gel: analysis of data from spontaneous reporting system in Poland and literature review","volume":"1","author":"Han S","year":"2011","unstructured":"Han S, Kar\u0142owicz-Bodalska K, Kuchar E. Safety of topical heparin gel: analysis of data from spontaneous reporting system in Poland and literature review. Biophilia. 2011, 1:4-10. 10.14813\/ibra.1.4_10","journal-title":"Biophilia"},{"key":"ref7","article-title":"Clinical contribution to pharmacology in venous pathology and its complications. Effects of heparin in gel form","volume":"35","author":"D'Amico N","year":"1987","unstructured":"D'Amico N, Greco N, Ruotolo G, Colonna CV. Clinical contribution to pharmacology in venous pathology and its complications. Effects of heparin in gel form. Minerva Cardioangiol. 1987, 35:195-203.","journal-title":"Minerva Cardioangiol"},{"key":"ref8","article-title":"Clinical experimentation of a gel with a high heparin contents","volume":"10","author":"Inga C","year":"1985","unstructured":"Inga C, Pignocchino P, Casini A, Coloma C. Clinical experimentation of a gel with a high heparin contents. Minerva Angiol. 1985, 10:247-9.","journal-title":"Minerva Angiol"},{"key":"ref9","article-title":"Valuation of Effectiveness and Tolerance of Heparin Sodium in the Pharmaceutical Form of Gel for Topical Use: A Double Blind Investigation. Clinical Study Report 53513","author":"Spigonardo F","year":"1985","unstructured":"Spigonardo F, Di Nardo E, Possati F. Valuation of Effectiveness and Tolerance of Heparin Sodium in the Pharmaceutical Form of Gel for Topical Use: A Double Blind Investigation. Clinical Study Report 53513. Menarini Group, Florence; 1985."},{"key":"ref10","article-title":"A Controlled \"Double-Blind\" Randomized Clinical Trial to Appraise Activity an Tolerance of the Preparation Lioton 1000 Gel Versus Placebo in the Treatment of Surface Thrombophlebitis: Clinical Study Report","author":"Ungar F","year":"1988","unstructured":"Ungar F. A Controlled \"Double-Blind\" Randomized Clinical Trial to Appraise Activity an Tolerance of the Preparation Lioton 1000 Gel Versus Placebo in the Treatment of Surface Thrombophlebitis: Clinical Study Report. Menarini Group, Florence; 1988."},{"key":"ref11","article-title":"Trend of blood and plasma viscosity and serum lipids following topical treatment with heparin sodium","volume":"4","author":"Pola P","year":"1984","unstructured":"Pola P, Tondi P, Flore R, Dal Lago A, Fioroni G, Pratesi C, Rega L. Trend of blood and plasma viscosity and serum lipids following topical treatment with heparin sodium. Giron Ital Angiol. 1984, 4:135-8.","journal-title":"Giron Ital Angiol"},{"key":"ref12","article-title":"Treatment of limbis phlebitic pathologies with gel containing heparin sodium","volume":"9","author":"Cappelli R","year":"1985","unstructured":"Cappelli R. Treatment of limbis phlebitic pathologies with gel containing heparin sodium. Farmaci. 1985, 9:163-7.","journal-title":"Farmaci"},{"key":"ref13","article-title":"The use of sodic heparin gel in inflammatory venous diseases of the lower limbs","volume":"3","author":"Milio G","year":"1985","unstructured":"Milio G, Ferrara F, Cospite M. The use of sodic heparin gel in inflammatory venous diseases of the lower limbs. Acta Cardiol Medit. 1985, 3:283-8.","journal-title":"Acta Cardiol Medit"},{"key":"ref14","article-title":"Post-marketing surveillance investigation on a heparin preparation for topical use","volume":"4","author":"Colonna CV","year":"1987","unstructured":"Colonna CV, Carlesi RM, Grossi E. Post-marketing surveillance investigation on a heparin preparation for topical use. Farmaci. 1987, 4:95-103.","journal-title":"Farmaci"},{"key":"ref15","article-title":"Local application of heparin-feasibility of its use in phlebology","volume":"75","author":"Navratilova Z","year":"2000","unstructured":"Navratilova Z, Semradova V. Local application of heparin-feasibility of its use in phlebology. Ces-Slov Derm Cesko-Slov Dermatol. 2000, 75:230-2.","journal-title":"Ces-Slov Derm Cesko-Slov Dermatol"},{"key":"ref16","article-title":"Surveillance of heparin (Lioton) in therapy of superficial phlebitis","volume":"8","author":"Bihari B","year":"2001","unstructured":"Bihari B. Surveillance of heparin (Lioton) in therapy of superficial phlebitis. Vasc Dis. 2001, 8:19-24.","journal-title":"Vasc Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050575","article-title":"Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter. A double-blind, randomized, placebo-controlled trial","volume":"54","author":"Vilardell M","year":"1999","unstructured":"Vilardell M, Sabat D, Arnaiz JA, Bleda MJ, Castel JM, Laporte JR, Vallv\u00e9 C. Topical heparin for the treatment of acute superficial phlebitis secondary to indwelling intravenous catheter. A double-blind, randomized, placebo-controlled trial. Eur J Clin Pharmacol. 1999, 54:917-21. 10.1007\/s002280050575","journal-title":"Eur J Clin Pharmacol"},{"key":"ref18","article-title":"Evaluation of the results obtained by local treatment with heparin in the form of the gel in athletes\u2019 traumatic injuries","volume":"19","author":"Velluti C","year":"1985","unstructured":"Velluti C, Piso L, Piras G. Evaluation of the results obtained by local treatment with heparin in the form of the gel in athletes\u2019 traumatic injuries. La Riabilitazione. 1985, 19:19-29.","journal-title":"La Riabilitazione"},{"key":"ref19","article-title":"Clinical considerations on a gel containing heparin sodium in the diseases of lower limb venous system","volume":"11","author":"Virgilio V","year":"1985","unstructured":"Virgilio V, Cavallaro S. Clinical considerations on a gel containing heparin sodium in the diseases of lower limb venous system. Ric Med. 1985, 11:1-5.","journal-title":"Ric Med"},{"key":"ref20","article-title":"Clinical experience with a gel containing heparin in high concentration (Lioton 1000 gel-Menarini) in minor sports injuries","volume":"39","author":"Colombo L","year":"1986","unstructured":"Colombo L, Colonna CV, Grossi E. Clinical experience with a gel containing heparin in high concentration (Lioton 1000 gel-Menarini) in minor sports injuries. Med Sport. 1986, 39:279-84.","journal-title":"Med Sport"},{"key":"ref21","article-title":"The advantages of percutaneous use of heparin in the phlebologic therapy","volume":"6","author":"Marrapodi E","year":"1986","unstructured":"Marrapodi E, Bocci L, Cipriani C, Colonna C, Corsi C. The advantages of percutaneous use of heparin in the phlebologic therapy. Giorn Ital Angiol. 1986, 6:115-22.","journal-title":"Giorn Ital Angiol"},{"key":"ref22","article-title":"Trial of effectivity of Lioton\u00ae 100,000 gel in lower limb varicosity syndrome","volume":"3","author":"Dar\u00f3czy J","year":"2002","unstructured":"Dar\u00f3czy J. Trial of effectivity of Lioton\u00ae 100,000 gel in lower limb varicosity syndrome. \u00c9rbetegsegek. 2002, 3:85-90.","journal-title":"\u00c9rbetegsegek"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006898","article-title":"Chronic venous insufficiency","volume":"130","author":"Eberhardt RT","year":"2014","unstructured":"Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014, 130:333-46. 10.1161\/CIRCULATIONAHA.113.006898","journal-title":"Circulation"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40119-021-00213-x","article-title":"Management of lower extremity pain from chronic venous insufficiency: a comprehensive review","volume":"10","author":"Orhurhu V","year":"2021","unstructured":"Orhurhu V, Chu R, Xie K, et al.. Management of lower extremity pain from chronic venous insufficiency: a comprehensive review. Cardiol Ther. 2021, 10:111-40. 10.1007\/s40119-021-00213-x","journal-title":"Cardiol Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X18755928","article-title":"Superficial vein thrombosis","volume":"23","author":"Evans NS","year":"2018","unstructured":"Evans NS, Ratchford EV. Superficial vein thrombosis. Vasc Med. 2018, 23:187-89. 10.1177\/1358863X18755928","journal-title":"Vasc Med"},{"key":"ref26","article-title":"Lioton-1000 gel in the prevention of thrombosis of the major veins of the extremities","volume":"1","author":"Novosad EM","year":"1999","unstructured":"Novosad EM. Lioton-1000 gel in the prevention of thrombosis of the major veins of the extremities. Lik Sprava. 1999, 1:122-4.","journal-title":"Lik Sprava"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912072","article-title":"Fondaparinux for the treatment of superficial-vein thrombosis in the legs","volume":"363","author":"Decousus H","year":"2010","unstructured":"Decousus H, Prandoni P, Mismetti P, et al.. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med. 2010, 363:1222-32. 10.1056\/NEJMoa0912072","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl070","article-title":"The aetiology of deep venous thrombosis","volume":"99","author":"Malone PC","year":"2006","unstructured":"Malone PC, Agutter PS. The aetiology of deep venous thrombosis. J Assoc Physicians. 2006, 99:581-93. 10.1093\/qjmed\/hcl070","journal-title":"J Assoc Physicians"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526\/a000497","article-title":"Risk factors for superficial vein thrombosis in patients with primary chronic venous disease","volume":"45","author":"Musil D","year":"2016","unstructured":"Musil D, Kaletova M, Herman J. Risk factors for superficial vein thrombosis in patients with primary chronic venous disease. Vasa. 2016, 45:63-6. 10.1024\/0301-1526\/a000497","journal-title":"Vasa"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.1590\/S1677-54492008000200007","article-title":"Superficial thrombophlebitis: epidemiology, physiopathology, diagnosis and treatment","volume":"7","author":"Sobreira ML","year":"2008","unstructured":"Sobreira ML, Yoshida WB, Last\u00f3ria S. Superficial thrombophlebitis: epidemiology, physiopathology, diagnosis and treatment. J Vasc Bras. 2008, 7:131-43.","journal-title":"J Vasc Bras"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2039","article-title":"Superficial thrombophlebitis (superficial venous thrombosis)","volume":"350","author":"Nasr H","year":"2015","unstructured":"Nasr H, Scriven JM. Superficial thrombophlebitis (superficial venous thrombosis). BMJ. 2015, 350:h2039. 10.1136\/bmj.h2039","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab495","article-title":"Chronic venous insufficiency, cardiovascular disease, and mortality: a population study","volume":"42","author":"Prochaska JH","year":"2021","unstructured":"Prochaska JH, Arnold N, Falcke A, et al.. Chronic venous insufficiency, cardiovascular disease, and mortality: a population study. Eur Heart J. 2021, 42:4157-65. 10.1093\/eurheartj\/ehab495","journal-title":"Eur Heart J"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.318322","article-title":"Epidemiology and genetics of venous thromboembolism and chronic venous disease","volume":"128","author":"Baylis RA","year":"2021","unstructured":"Baylis RA, Smith NL, Klarin D, Fukaya E. Epidemiology and genetics of venous thromboembolism and chronic venous disease. Circ Res. 2021, 128:1988-2002. 10.1161\/CIRCRESAHA.121.318322","journal-title":"Circ Res"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1024\/0301-1526.38.4.293","article-title":"Varicose veins and chronic venous insufficiency","volume":"38","author":"Partsch H","year":"2009","unstructured":"Partsch H. Varicose veins and chronic venous insufficiency. Vasa. 2009, 38:293-301. 10.1024\/0301-1526.38.4.293","journal-title":"Vasa"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejvs.2015.05.013","article-title":"Association of venous disorders with leg symptoms: results from the Bonn Vein Study 1","volume":"50","author":"Wrona M","year":"2015","unstructured":"Wrona M, J\u00f6ckel KH, Pannier F, Bock E, Hoffmann B, Rabe E. Association of venous disorders with leg symptoms: results from the Bonn Vein Study 1. Eur J Vasc Endovasc Surg. 2015, 50:360-7. 10.1016\/j.ejvs.2015.05.013","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(02)00518-8","article-title":"Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study","volume":"56","author":"Lee AJ","year":"2003","unstructured":"Lee AJ, Evans CJ, Allan PL, Ruckley CV, Fowkes FGR. Lifestyle factors and the risk of varicose veins: Edinburgh Vein Study. J Clin Epidemiol. 2003, 56:171-9. 10.1016\/s0895-4356(02)00518-8","journal-title":"J Clin Epidemiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2217\/epi-2018-0001","article-title":"DNA methylation and gene expression profiling reveal MFAP5 as a regulatory driver of extracellular matrix remodeling in varicose vein disease","volume":"10","author":"Smetanina MA","year":"2018","unstructured":"Smetanina MA, Kel AE, Sevost'Ianova KS, et al.. DNA methylation and gene expression profiling reveal MFAP5 as a regulatory driver of extracellular matrix remodeling in varicose vein disease. Epigenomics. 2018, 10:1103-19. 10.2217\/epi-2018-0001","journal-title":"Epigenomics"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1067\/mva.2003.61","article-title":"Does severe venous insufficiency have a different etiology in the morbidly obese? Is it venous?","volume":"37","author":"Padberg F Jr","year":"2003","unstructured":"Padberg F Jr, Cerveira JJ, Lal BK, Pappas PJ, Varma S, Hobson RW 2nd. Does severe venous insufficiency have a different etiology in the morbidly obese? Is it venous?. J Vasc Surg. 2003, 37:79-85. 10.1067\/mva.2003.61","journal-title":"J Vasc Surg"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200107000-00007","article-title":"Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease","volume":"234","author":"Sugerman HJ","year":"2001","unstructured":"Sugerman HJ, Sugerman EL, Wolfe L, Kellum JM Jr, Schweitzer MA, DeMaria EJ. Risks and benefits of gastric bypass in morbidly obese patients with severe venous stasis disease. Ann Surg. 2001, 234:41-6. 10.1097\/00000658-200107000-00007","journal-title":"Ann Surg"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1177\/153857440203600404","article-title":"The influence of obesity on chronic venous disease","volume":"36","author":"Danielsson G","year":"2002","unstructured":"Danielsson G, Eklof B, Grandinetti A, Kistner RL. The influence of obesity on chronic venous disease. Vasc Endovascular Surg. 2002, 36:271-6. 10.1177\/153857440203600404","journal-title":"Vasc Endovascular Surg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1177\/0003319714541988","article-title":"Chronic venous disease and comorbidities","volume":"66","author":"Matic P","year":"2015","unstructured":"Matic P, Jolic S, Tanaskovic S, Soldatovic I, Katsiki N, Isenovic E, Radak DJ. Chronic venous disease and comorbidities. Angiology. 2015, 66:539-44. 10.1177\/0003319714541988","journal-title":"Angiology"},{"key":"ref42","unstructured":"European Medicines Agency (EMA). Public data from article 57 database. (2023). Accessed. April 2023: https:\/\/www.ema.europa.eu\/en\/human-regulatory\/post-authorisation\/data-medicines-iso-idmp-standards\/public-data-articl...."},{"key":"ref43","article-title":"Double-Blind Controlled Trial With Lioton Cream and Gel: Clinical Study Report","author":"Agrifoglio G","year":"1977","unstructured":"Agrifoglio G. Double-Blind Controlled Trial With Lioton Cream and Gel: Clinical Study Report. Menarini Group, Florence; 1977."},{"key":"ref44","article-title":"Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study","volume":"53","author":"Belcaro G","year":"2011","unstructured":"Belcaro G, Cesarone MR, Dugall M, et al.. Topical formulation of heparin is effective in reducing the symptoms of superficial venous thrombosis: a monocenter, observer-blind, placebo-controlled randomized study. Panminerva Med. 2011, 53:3-11.","journal-title":"Panminerva Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.4103\/ijp.IJP_201_17","article-title":"A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU\/ml) compared to heparin topical gel (200 IU\/g) in prevention of infusion-associated phlebitis","volume":"50","author":"Saini V","year":"2018","unstructured":"Saini V, Samra T, Ahuja N, Sethi S. A prospective randomized study to evaluate safety and efficacy of heparin topical solution (1000 IU\/ml) compared to heparin topical gel (200 IU\/g) in prevention of infusion-associated phlebitis. Indian J Pharmacol. 2018, 50:344-9. 10.4103\/ijp.IJP_201_17","journal-title":"Indian J Pharmacol"},{"key":"ref46","article-title":"The prophylactic use of a topical scar gel containing extract of Allium cepae, allantoin, and heparin improves symptoms and appearance of cesarean-section scars compared with untreated scars","volume":"13","author":"Ocampo-Candiani J","year":"2014","unstructured":"Ocampo-Candiani J, V\u00e1zquez-Mart\u00ednez OT, Iglesias Benavides JL, Buske K, Lehn A, Acker C. The prophylactic use of a topical scar gel containing extract of Allium cepae, allantoin, and heparin improves symptoms and appearance of cesarean-section scars compared with untreated scars. J Drugs Dermatol. 2014, 13:176-82.","journal-title":"J Drugs Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1136\/bjsm.36.3.183","article-title":"Escin\/diethylammonium salicylate\/heparin combination gels for the topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study","volume":"36","author":"Wetzel D","year":"2002","unstructured":"Wetzel D, Menke W, Dieter R, Smasal V, Giannetti B, Bulitta M. Escin\/diethylammonium salicylate\/heparin combination gels for the topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Br J Sports Med. 2002, 36:183-8. 10.1136\/bjsm.36.3.183","journal-title":"Br J Sports Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200828100-00001","article-title":"Topically applied heparins for the treatment of vascular disorders: a comprehensive review","volume":"28","author":"Vecchio C","year":"2008","unstructured":"Vecchio C, Frisinghelli A. Topically applied heparins for the treatment of vascular disorders: a comprehensive review. Clin Drug Investig. 2008, 28:603-14. 10.2165\/00044011-200828100-00001","journal-title":"Clin Drug Investig"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004982.pub6","article-title":"Treatment for superficial thrombophlebitis of the leg","volume":"2","author":"Di Nisio M","year":"2018","unstructured":"Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Cochrane Database Syst Rev. 2018, 2:CD004982. 10.1002\/14651858.CD004982.pub6","journal-title":"Cochrane Database Syst Rev"},{"key":"ref50","article-title":"Our experience on the use of heparin sodium by iontophoresis and for topical use in varicose pathologies of lower limbs, as a potentiation of physiokinesitherapy","volume":"41","author":"Calabrese GSG","year":"1986","unstructured":"Calabrese GSG, Lionetti P. Our experience on the use of heparin sodium by iontophoresis and for topical use in varicose pathologies of lower limbs, as a potentiation of physiokinesitherapy. La Clinica. 1986, 41:1-27.","journal-title":"La Clinica"},{"key":"ref51","article-title":"Pharmacological, toxicological and teratological trial of the medicinal speciality Lioton (Menarini Internal Report)","author":"Dubini F","year":"1977","unstructured":"Dubini F, Genovese E. Pharmacological, toxicological and teratological trial of the medicinal speciality Lioton (Menarini Internal Report). Menarini Group Report. 1977."},{"key":"ref52","article-title":"The permeation of heparin through human skin","volume":"16","author":"Stuttgen G","year":"1990","unstructured":"Stuttgen G, Bauer E. The permeation of heparin through human skin. Acta Ther. 1990, 16:265-76.","journal-title":"Acta Ther"},{"key":"ref53","article-title":"Permeation of the human skin by heparin and mucopolysaccharide polysulfuric acid ester","volume":"40","author":"St\u00fcttgen G","year":"1990","unstructured":"St\u00fcttgen G, Panse P, Bauer E. Permeation of the human skin by heparin and mucopolysaccharide polysulfuric acid ester. Arzneimittelforschung. 1990, 40:484-9.","journal-title":"Arzneimittelforschung"},{"key":"ref54","article-title":"Photosensitisation Study in the Guinea Pig. Test Substance Lioton\u00ae Gel. Report 4182\/T\/124\/94","author":"Menarini Group","year":"1994","unstructured":"Menarini Group.  Photosensitisation Study in the Guinea Pig. Test Substance Lioton\u00ae Gel. Report 4182\/T\/124\/94. Research Toxicology Center S.p.A, Pomezia; 1994."},{"key":"ref55","article-title":"Acute Dermal Irritation Study in the Albino Rabbit. Test Substance Lioton\u00ae Gel. Report 4181\/T\/045\/94","author":"Menarini Group","year":"1994","unstructured":"Menarini Group. Acute Dermal Irritation Study in the Albino Rabbit. Test Substance Lioton\u00ae Gel. Report 4181\/T\/045\/94. Research Toxicology Center S.p.A, Pomezia; 1994."},{"key":"ref56","article-title":"Delayed Dermal Sensitisation Study in the Guinea Pig. Test Substance Lioton\u00ae Gel. Report 4180\/T\/097\/94.","author":"Menarini Group","year":"1994","unstructured":"Menarini Group. Delayed Dermal Sensitisation Study in the Guinea Pig. Test Substance Lioton\u00ae Gel. Report 4180\/T\/097\/94.. Research Toxicology Center S.p.A, Pomezia; 1994."},{"key":"ref57","article-title":"Acute Eye Irritation Study in the Albino Rabbit. Test Substance: Lioton\u00ae Gel Report 4179\/T\/048\/94","author":"Menarini Group","year":"1994","unstructured":"Menarini Group. Acute Eye Irritation Study in the Albino Rabbit. Test Substance: Lioton\u00ae Gel Report 4179\/T\/048\/94. Research Toxicology Center S.p.A, Pomezia; 1994."},{"key":"ref58","unstructured":"Austrian Federal Office for Safety in Health Care. Lioton\u00ae 1000 IE\/g gel. Summary of product characteristics. (2022). Accessed. April 2023: https:\/\/aspregister.basg.gv.at\/aspregister\/faces\/aspregister.jspx."},{"key":"ref59","unstructured":"AEMPS (Spanish Agency for Medicine and Health Products). Menaven\u00ae 1000 UI gel. Summary of product characteristics. (2022). Accessed. April 2023: https:\/\/cima.aemps.es\/cima\/dochtml\/ft\/58678\/FT_58678.html#1-nombre-del-medicamento."},{"key":"ref60","unstructured":"AEMPS. Resolution No. 58678 that modifies the marketing authorization of the medication Menaven\u00ae 1000 UI\/g gel. (2020). Accessed. April 2023: https:\/\/www.aemps.gob.es\/."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/154864-review-of-topical-sodium-heparin-1000-iug-gel-in-symptomatic-uncomplicated-superficial-thrombophlebitis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:26Z","timestamp":1707508406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/154864-review-of-topical-sodium-heparin-1000-iug-gel-in-symptomatic-uncomplicated-superficial-thrombophlebitis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,21]]},"references-count":60,"URL":"https:\/\/doi.org\/10.7759\/cureus.47418","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,21]]}}}